Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Gale

Showing results (301-310 of 359) with videos related to

Pageof 36
Sort By:
Stem Cell Reports|March 3, 2021
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical FunctionSilvia Marchiano, Tien-Ying Hsiang, Akshita Khanna, et al.
Research Square|April 8, 2025
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Frontiers in Immunology|June 4, 2025
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.
Science (New York, N.Y.)|April 28, 2007
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingJeffrey A Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, et al.
Cancer Research|December 20, 2007
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinibJeffrey A Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, et al.
Nature Immunology|May 30, 2017
The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunityJacquelyn A Gorman, Christian Hundhausen, John S Errett, et al.
JCI Insight|February 8, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infectionYueh-Ming Loo, David M Owen, Kui Li, et al.
Pageof 36

Showing results (301-310 of 359) with videos related to

Sort By:
Pageof 36
Stem Cell Reports|March 3, 2021
SARS-CoV-2 Infects Human Pluripotent Stem Cell-Derived Cardiomyocytes, Impairing Electrical and Mechanical FunctionSilvia Marchiano, Tien-Ying Hsiang, Akshita Khanna, et al.
Research Square|April 8, 2025
SIV/SARS-CoV-2 co-infection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Frontiers in Immunology|June 4, 2025
SIV/SARS-CoV-2 coinfection in rhesus macaques impacts viral shedding, host immunity, the microbiome, and viral evolutionMegan N Fredericks, Zohar Kolodner, Adam Waalkes, et al.
Nature|November 19, 2010
2'-O methylation of the viral mRNA cap evades host restriction by IFIT family membersStephane Daffis, Kristy J Szretter, Jill Schriewer, et al.
Science (New York, N.Y.)|April 28, 2007
MET amplification leads to gefitinib resistance in lung cancer by activating ERBB3 signalingJeffrey A Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, et al.
Cancer Research|December 20, 2007
PF00299804, an irreversible pan-ERBB inhibitor, is effective in lung cancer models with EGFR and ERBB2 mutations that are resistant to gefitinibJeffrey A Engelman, Kreshnik Zejnullahu, Christopher-Michael Gale, et al.
Nature Immunology|May 30, 2017
The A946T variant of the RNA sensor IFIH1 mediates an interferon program that limits viral infection but increases the risk for autoimmunityJacquelyn A Gorman, Christian Hundhausen, John S Errett, et al.
JCI Insight|February 8, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
Medrxiv : the Preprint Server for Health Sciences|February 4, 2022
T cell response to intact SARS-CoV-2 includes coronavirus cross-reactive and variant-specific componentsLichen Jing, Xia Wu, Maxwell P Krist, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 6, 2006
Viral and therapeutic control of IFN-beta promoter stimulator 1 during hepatitis C virus infectionYueh-Ming Loo, David M Owen, Kui Li, et al.
Pageof 36